Evidence map›Paper›PMID 29126447›Full record

ArticleLipids in health and disease2017

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).

Mahwish, Farhan Saeed, Muhammad Sajid Arshad, Mahr Un Nisa, Muhammad Tahir Nadeem, Muhammad Umair Arshad

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. The metabolic effect ofFrontiers in nutrition · 2023
    Pooled it
  2. The Biochemical Role of Bitter Melon (Food science & nutrition · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Transcriptome and metabolome changes induced by bitter melon (Journal of traditional and complementary medicine · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

MahwishInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan.
Farhan SaeedInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan.
Muhammad Sajid ArshadInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan. sajid_ft@yahoo.com.
Mahr Un NisaInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan.
Muhammad Tahir NadeemInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan.
Muhammad Umair ArshadInstitute of Home & Food Sciences, Government College University, Faisalabad, 38040, Pakistan.
Government College University, Faisalabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular diseases and diabetes are responsible for large number of deaths throughout the globe. Bitter gourd has the potential to become a component of the diet or a dietary supplement for diabetic and pre-diabetic patients owing to the presence of insulin like molecules. Recent investigations have suggested that bitter gourd extracts may ameliorate high fat diet induced obesity and hyperlipidemia in animal models. Moreover, its supplements in food result in lowering weight gain and visceral fat mass.

methodsThe current study was designed to investigate the nutraceutical potential of skin, flesh and whole fruit of bitter gourd cultivars against hyperglycemia and hyperlipidemia. For the purpose, various bitter gourd cultivars were procured from local market. Bio-evaluation studies were carried out on biochemical parameters using rodent experiment model.

resultsFrom results, it was revealed that maximum reduction in blood glucose skin 1.06%, flesh 2.65%, whole fruit 4.29%, total cholesterol skin 6.60%, flesh 6.04%, whole fruit 6.70%, low density lipoprotein skin 5.55%, flesh 6.81%, whole fruit 6.60%, and triglycerides skin 0.04%, flesh 3.38%, whole fruit 2.02%, were observed. Moreover, insulin skin 2.14%, flesh 3.52%, whole fruit 2.73%, production was slightly enhanced with improved levels of high density lipoprotein in whole fruit of bitter gourd.

conclusionOverwhelmingly, it may be inferred here that bitter gourd holds the potential to significantly improve diabetic conditions and associated late complications with no ill effects on body organs.

Indexed as

AnimalsFruitHypoglycemic AgentsHypolipidemic AgentsMaleMomordica charantiaPlant ExtractsRatsRats, Sprague-DawleyHypoglycemic AgentsHypolipidemic AgentsPlant ExtractsBitter gourdFunctional foodsHyperglycemiaHyperlipidemiaNutraceutical

Identifiers

PMID29126447
PMCPMC5681810
OpenAlexW2767818755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.